PKR (PRKR) Antibody (T535) Blocking peptide

Interferon-induced, double-stranded RNA-activated protein kinase, Eukaryotic translation initiation factor 2-alpha kinase 2, eIF-2A protein kinase 2, Interferon-inducible RNA-dependent protein kinase, P1/eIF-2A protein kinase, Protein kinase RNA-activated, PKR, Protein kinase R, Tyrosine-protein kinase EIF2AK2, p68 kinase, EIF2AK2, PKR, PRKR

The synthetic peptide sequence was selected from the C-term region of human PRKR-T535 (C-term) . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.